Form 4 for OMCL OMNICELL, INC.
Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-08 · accession 0001415889-25-007666 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-11 | 2025-03-08 | OMCL | Etta Nchacha | EVP, CFO | F - Tax | $36.99 | -5,368 | 132.0K | -4% | -$198.6K | |
| 2025-03-11 | 2025-03-08 | OMCL | Etta Nchacha | EVP, CFO | A - Grant | $0.00 | +66.6K | 137.4K | +94% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-08 | F | D | 5,368 | $36.99 | 132,023 | D | — | — | (F2) Reflects withholding of shares to cover taxes due in connection with the vesting of performance-based restricted stock units. |
| 2 | Common | Common Stock | 2025-03-08 | A | A | 66,633 | $0.00 | 137,391 | D | — | — | (F1) Reflects performance-based restricted stock units that were previously granted on February 27, 2024, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 8, 2025 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 66,633 performance-based restricted stock units (176% of target) of which 25% vested upon the determination date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively). |